IL15 and cancer: Conversely, IL-15 from other sources, including dendritic, stromal, and endothelial cells, did not seem to affect intratumoral g1 ILCs, strongly suggesting that IL-15 trans-presentation by cancer cells might contribute to directly activating ILC1ls and promoting their phenotype [70].